Abstract
Pediatric current and potential indications of alpha-interferon (alpha-IFN) are reviewed. Further prospective studies are needed for myeloproliferative diseases, acute leukemias, chronic hepatitis severe hemangiomas, and chronic idiopathic thrombocytopenic purpura (ITP).
MeSH terms
-
Child
-
Chronic Disease
-
Hemangioma / drug therapy
-
Hepatitis, Viral, Human / drug therapy
-
Humans
-
Interferon Type I / adverse effects
-
Interferon Type I / therapeutic use*
-
Leukemia / drug therapy
-
Pediatrics*
-
Purpura, Thrombocytopenic, Idiopathic / drug therapy
-
Recombinant Proteins
Substances
-
Interferon Type I
-
Recombinant Proteins